This Week in the Circuits: Insurers Defend Decision to Not Cover Popular Weight-Loss Drugs
The First Circuit will consider two lawsuits alleging insurers are discriminating against their policyholders by failing to cover popular GLP-1 drugs like Ozempic when they are prescribed for obesity.